Zuchwil, Switzerland

Thomas Meyer

This inventor holds 3 USPTO granted patents and 8 published patent applications and 4 EPO patents. Top assignees: Altamira Medica Ag, Auris Medical Ag, Otolanum Ag. Active years: 2015-2025.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas Meyer: Innovator in Pharmaceutical Compositions

Introduction

Thomas Meyer is a notable inventor based in Zuchwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on innovative compositions aimed at preventing infections and treating various disorders.

Latest Patents

Meyer’s latest patents include a composition for preventing infection, which involves an aqueous formulation comprising a mucoadhesive polymer and clay particles. This invention presents methods for treating or preventing infections effectively. Another significant patent is a pharmaceutical composition that includes betahistine, designed for the treatment of otological or neurological disorders through intranasal application.

Career Highlights

Throughout his career, Thomas Meyer has worked with prominent companies such as Auris Medical AG and Altamira Medica AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Meyer has collaborated with notable professionals in his field, including Fabio Fais and Christopher John Wraight. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Thomas Meyer stands out as an influential inventor in the pharmaceutical industry, with a focus on innovative solutions for infection prevention and treatment. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…